Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 316.18M | 297.03M | 289.46M | 306.10M | 303.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 316.18M | 297.03M | 289.46M | 306.10M | 303.43M |
| Cost of Revenue | 101.08M | 100.27M | 101.36M | 104.39M | 98.00M |
| Gross Profit | 215.10M | 196.76M | 188.10M | 201.71M | 205.43M |
| SG&A Expenses | 149.37M | 118.99M | 111.71M | 109.02M | 107.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 271.60M | 244.27M | 236.94M | 237.40M | 231.41M |
| Operating Income | 44.58M | 52.76M | 52.52M | 68.70M | 72.02M |
| Income Before Tax | 38.27M | 42.88M | 40.17M | 41.66M | 61.08M |
| Income Tax Expenses | 15.69M | 7.99M | 6.57M | 1.07M | 12.03M |
| Earnings from Continuing Operations | 22.59M | 34.89M | 33.60M | 40.59M | 49.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.59M | 34.89M | 33.60M | 40.59M | 49.06M |
| EBIT | 44.58M | 52.76M | 52.52M | 68.70M | 72.02M |
| EBITDA | 72.15M | 79.84M | 80.66M | 96.76M | 99.33M |
| EPS Basic | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 |
| Normalized Basic EPS | 0.18 | 0.19 | 0.21 | 0.26 | 0.26 |
| EPS Diluted | 0.14 | 0.22 | 0.21 | 0.26 | 0.31 |
| Normalized Diluted EPS | 0.17 | 0.19 | 0.20 | 0.25 | 0.26 |
| Average Basic Shares Outstanding | 157.37M | 158.43M | 158.53M | 157.87M | 157.31M |
| Average Diluted Shares Outstanding | 158.94M | 160.63M | 161.12M | 160.65M | 160.50M |
| Dividend Per Share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Payout Ratio | 55.69% | 36.50% | 37.76% | 31.11% | 25.64% |